Table 1.
Vaccine + bsAbs | Interactions T cells-tumor cells |
Mechanisms | Response characteristics | Autoimmunity |
---|---|---|---|---|
TA + bsCD3 + bsCD28 | Cognate | Restimulation (memory)/TA cross-presentation via DCs (naive) ⇒ TA-specific T cell activation | Long-term effect systemic | Low risk |
| ||||
bsCD3 + bsCD28 | Noncognate | Provision of inflammatory and danger signals ⇒ Non-TA-specific T cell activation | Transient, local | High risk |